GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SGX:T14) » Definitions » Beginning Cash Position

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Beginning Cash Position : $277 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Beginning Cash Position?

Tianjin Pharmaceutical Da Ren Tang Group's Beginning Cash Position for the quarter that ended in Mar. 2024 was $277 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly Beginning Cash Position declined from Sep. 2023 ($274 Mil) to Dec. 2023 ($270 Mil) but then increased from Dec. 2023 ($270 Mil) to Mar. 2024 ($277 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual Beginning Cash Position increased from Dec. 2021 ($312 Mil) to Dec. 2022 ($327 Mil) and increased from Dec. 2022 ($327 Mil) to Dec. 2023 ($380 Mil).


Tianjin Pharmaceutical Da Ren Tang Group Beginning Cash Position Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Beginning Cash Position Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 207.46 226.23 312.02 327.49 379.76

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 393.50 459.95 274.26 270.13 277.36

Tianjin Pharmaceutical Da Ren Tang Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Tianjin Pharmaceutical Da Ren Tang Group Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Headlines

No Headlines